Shareholder rights law firm Robbins LLP is investigating Enochian Biosciences Inc. (NASDAQ: ENOB) and its officers and directors to evaluate whether they violated securities laws or breached
fiduciary duties by overstating the Company’s commercial prospects for its product pipeline. Enochian is a pre-clinical stage biotechnology company that purportedly researches and develops
pharmaceutical and